Cargando…
S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428276/ http://dx.doi.org/10.1097/01.HS9.0000967696.13096.54 |
| _version_ | 1785090429208756224 |
|---|---|
| author | Mohty, Mohamad Tomasson, Michael H. Arnulf, Bertrand Bahlis, Nizar J Rodríguez-Otero, Paula Martinez-Lopez, Joaquín Touzeau, Cyrille Quach, Hang Depaus, Julien Yokoyama, Hisayuki Manier, Salomon Raje, Noopur Raab, Marc S. Searle, Emma Leip, Eric Sullivan, Sharon T. Czibere, Akos Viqueira, Andrea Lesokhin, Alexander |
| author_facet | Mohty, Mohamad Tomasson, Michael H. Arnulf, Bertrand Bahlis, Nizar J Rodríguez-Otero, Paula Martinez-Lopez, Joaquín Touzeau, Cyrille Quach, Hang Depaus, Julien Yokoyama, Hisayuki Manier, Salomon Raje, Noopur Raab, Marc S. Searle, Emma Leip, Eric Sullivan, Sharon T. Czibere, Akos Viqueira, Andrea Lesokhin, Alexander |
| author_sort | Mohty, Mohamad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428276 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104282762023-08-17 S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3 Mohty, Mohamad Tomasson, Michael H. Arnulf, Bertrand Bahlis, Nizar J Rodríguez-Otero, Paula Martinez-Lopez, Joaquín Touzeau, Cyrille Quach, Hang Depaus, Julien Yokoyama, Hisayuki Manier, Salomon Raje, Noopur Raab, Marc S. Searle, Emma Leip, Eric Sullivan, Sharon T. Czibere, Akos Viqueira, Andrea Lesokhin, Alexander Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428276/ http://dx.doi.org/10.1097/01.HS9.0000967696.13096.54 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Mohty, Mohamad Tomasson, Michael H. Arnulf, Bertrand Bahlis, Nizar J Rodríguez-Otero, Paula Martinez-Lopez, Joaquín Touzeau, Cyrille Quach, Hang Depaus, Julien Yokoyama, Hisayuki Manier, Salomon Raje, Noopur Raab, Marc S. Searle, Emma Leip, Eric Sullivan, Sharon T. Czibere, Akos Viqueira, Andrea Lesokhin, Alexander S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3 |
| title | S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3 |
| title_full | S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3 |
| title_fullStr | S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3 |
| title_full_unstemmed | S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3 |
| title_short | S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3 |
| title_sort | s196: elranatamab, a b-cell maturation antigen (bcma)-cd3 bispecific antibody, for patients with relapsed/refractory multiple myeloma: extended follow up and biweekly administration from magnetismm-3 |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428276/ http://dx.doi.org/10.1097/01.HS9.0000967696.13096.54 |
| work_keys_str_mv | AT mohtymohamad s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT tomassonmichaelh s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT arnulfbertrand s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT bahlisnizarj s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT rodriguezoteropaula s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT martinezlopezjoaquin s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT touzeaucyrille s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT quachhang s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT depausjulien s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT yokoyamahisayuki s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT maniersalomon s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT rajenoopur s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT raabmarcs s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT searleemma s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT leiperic s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT sullivansharont s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT czibereakos s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT viqueiraandrea s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 AT lesokhinalexander s196elranatamababcellmaturationantigenbcmacd3bispecificantibodyforpatientswithrelapsedrefractorymultiplemyelomaextendedfollowupandbiweeklyadministrationfrommagnetismm3 |